Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

EGX:PHAR Income Statement

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	8,819	7,591	5,232	3,955	3,409	2,886
Revenue Growth (YoY)	39.02%	45.09%	32.27%	16.03%	18.13%	-15.40%
Cost of Revenue	4,969	4,244	2,983	2,397	1,957	1,675
Gross Profit	3,850	3,346	2,248	1,558	1,452	1,211
Selling, General & Admin	1,176	1,065	788.09	683.2	566.08	547.58
Research & Development	67.51	70.45	43.23	43.68	34.96	20.87
Other Operating Expenses	174.15	378.57	167.2	134.35	60.79	55.35
Operating Expenses	1,733	1,844	1,038	896.23	674.83	623.8
Operating Income	2,118	1,503	1,211	662	776.85	587.32
Interest Expense	-1,231	-928.54	-388.52	-195.42	-136.25	-83.16
Interest & Investment Income	292.24	72.05	26.24	57.77	32.11	40.57
Earnings From Equity Investments	151.58	151.58	74.51	-	-	37.18
Currency Exchange Gain (Loss)	208.8	699.88	139.63	286.4	-6.25	-11.55
Other Non Operating Income (Expenses)	36.95	11.04	1.51	-20.62	-24.04	13.37
EBT Excluding Unusual Items	1,576	1,509	1,064	790.13	642.41	583.74
Gain (Loss) on Sale of Assets	1.27	0.22	4.69	3.7	2.78	3.8
Pretax Income	1,577	1,509	1,069	793.83	645.19	587.55
Income Tax Expense	431.56	411.83	245.62	150.07	156.9	100.15
Earnings From Continuing Operations	1,145	1,097	823.31	643.76	488.29	487.4
Minority Interest in Earnings	-8.09	-1.21	-0.99	-0.78	-0.53	-0.89
Net Income	1,137	1,096	822.32	642.98	487.75	486.51
Net Income to Common	1,137	1,096	822.32	642.98	487.75	486.51
Net Income Growth	4.10%	33.25%	27.89%	31.83%	0.25%	-27.45%
Shares Outstanding (Basic)	149	149	149	99	99	98
Shares Outstanding (Diluted)	149	149	149	99	99	98
Shares Change (YoY)	-	-	50.00%	-	1.64%	-1.61%
EPS (Basic)	7.65	7.37	5.53	6.48	4.92	4.99
EPS (Diluted)	7.65	7.37	5.53	6.48	4.92	4.99
EPS Growth	4.10%	33.25%	-14.74%	31.83%	-1.36%	-26.26%
Free Cash Flow	-1,829	-4,121	-2,198	-859.77	-53.27	-38.7
Free Cash Flow Per Share	-12.30	-27.70	-14.77	-8.67	-0.54	-0.40
Dividend Per Share	1.500	1.500	1.000	1.000	1.500	-
Dividend Growth	50.00%	50.00%	-	-33.33%	-	-
Gross Margin	43.66%	44.09%	42.98%	39.40%	42.59%	41.97%
Operating Margin	24.01%	19.79%	23.14%	16.74%	22.79%	20.35%
Profit Margin	12.90%	14.44%	15.72%	16.26%	14.31%	16.86%
Free Cash Flow Margin	-20.74%	-54.29%	-42.01%	-21.74%	-1.56%	-1.34%
EBITDA	2,218	1,599	1,314	759.39	867.73	726.89
EBITDA Margin	25.15%	21.07%	25.12%	19.20%	25.46%	25.19%
D&A For EBITDA	100.9	96.53	103.17	97.39	90.88	139.57
EBIT	2,118	1,503	1,211	662	776.85	587.32
EBIT Margin	24.01%	19.79%	23.14%	16.74%	22.79%	20.35%
Effective Tax Rate	27.37%	27.30%	22.98%	18.90%	24.32%	17.04%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.